Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
IMVT

Immunovant, Inc. (IMVT)

NASDAQ
$34.19
-$0.86
(-2.45%)
Previous Close: ⁦$35.05⁩
Market Closed

Last updated: ⁦2026-11-16 06:04:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Immunovant, Inc. (IMVT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $34.19, with a market capitalization of $7.07B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $21.86 to $45.42. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$7.07B

$34.71

$36.00

$32.34

$35.05

680.58K

1.44M

--

$45.42

$21.86

--

--

Immunovant, Inc. (IMVT) Latest Closing Stock Price

Immunovant, Inc. (IMVT) last closed at $34.19 as of 2026-11-14 00:33:00, down 2.45% ($0.86) from the previous close of $35.05.

During the latest regular trading session, IMVT traded between $32.34 and $36.00, with a volume of 680.58K shares. The closing price was near the middle and near the middle of its 52-week range.

Immunovant, Inc. (IMVT) 7-Day Stock Price Change

Over the past seven days, Immunovant, Inc. (IMVT) moved from $28.39 to $34.19, representing a gain of 20.42% ($5.80).

The stock traded between $28.12 and $37.59 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 1.88 million shares, up versus the previous seven-day period, indicating higher trading activity.

IMVT 52-Week Price Position

Position in Range: 52.3%

52W Low$21.86
52W High$45.42

IMVT is currently trading at $34.19, placing it 52.3% of the way from its 52-week low of $21.86 to its 52-week high of $45.42. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Immunovant, Inc. (IMVT)?

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

Immunovant, Inc. Information

Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
315
Exchange
NASDAQ
Company Website

IMVT News

Latest news related to Immunovant, Inc. and IMVT stock.

  • Massive

    Does Immunovant (IMVT) Have the Potential to Rally 30.52% as Wall Street Analysts Expect?

    Immunovant (IMVT) has gained 24.4% over the past four weeks and Wall Street analysts project a mean price target of $46.61, indicating a potential 30.5% upside from current levels of $35.71. The stock has a Zacks Rank #2 (Buy) rating, supported by positive earnings estimate revisions, though the article cautions that price targets alone should not be the sole basis for investment decisions.

    Read Full Article
  • Massive

    Immunovant (IMVT) Upgraded to Buy: Here's What You Should Know

    Immunovant, Inc. (IMVT) received an upgrade to Zacks Rank #2 (Buy) based on upward trends in earnings estimates. The company's consensus estimate has increased 1.1% over the past three months. The upgrade positions IMVT in the top 20% of Zacks-covered stocks, suggesting potential near-term stock price appreciation driven by improving earnings outlook.

    Read Full Article

Ways to Trade IMVT at MEXC

IMVT MEXC RealStocks

Own real IMVT shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Immunovant, Inc. (IMVT) Stock on MEXC

Eligible investors can buy real shares of Immunovant, Inc. (IMVT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for IMVT and Place Your Order
Step 3: Search for IMVT and Place Your Order
Open the RealStocks trading page and search for IMVT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Immunovant, Inc. (IMVT) stock price today?
Immunovant, Inc. (IMVT) is currently trading at $34.19, down 2.45% ($0.86) from the previous close of $35.05. Intraday prices update in real time during regular trading hours.
2.Is IMVT stock going up or down today?
As of 2026-11-14 00:33:00, IMVT is trading at $34.19, down 2.45% ($0.86) from its previous close of $35.05. The stock has traded between $32.34 and $36.00 during today’s regular session. Past price movements do not guarantee future results.
3.What is IMVT pre-market price?
As of 2026-11-14 00:33:00, IMVT is trading at $36.00 in pre-market trading, up 2.72% ($0.95) from the previous close of $35.05. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is IMVT after-hours price?
As of 2026-11-14 00:33:00, IMVT is trading at $34.20 in after-hours trading, up 0.02% ($0.01) from the regular-session close of $34.19. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is IMVT stock trading now?
IMVT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does IMVT sit relative to its 52-week high and low?
Over the past 52 weeks, IMVT has traded between a low of $21.86 and a high of $45.42. At $34.19, the stock is positioned 52.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Immunovant, Inc. in?
Immunovant, Inc. (IMVT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Immunovant, Inc.'s market capitalization and where is it listed?
Immunovant, Inc. is listed on the NASDAQ exchange with a market capitalization of $7.07B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is IMVT valued in terms of P/E ratio and EPS?
IMVT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-2.46. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Immunovant, Inc. pay a dividend?
Immunovant, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Top Gainers

Browse today's leading gainers in the US stock market

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to IMVT, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

IMVT Stock Calculator

Estimate the value between IMVT shares and USD.

IMVT Shares to USD

IMVT Shares
IMVT
IMVT
USD
USD
USD

1.00 IMVT shares = 34.188 USD

Calculations are estimates based on the latest available price and are for reference only.